SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-20-065592
Filing Date
2020-05-26
Accepted
2020-05-26 06:08:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2018626-9_sc14d9c.htm SC14D9C 19433
2 EXHIBIT 99.1 tm2018626d9_ex99-1.htm EX-99.1 88136
3 GRAPHIC tm2018626d9_ex99-1img01.jpg GRAPHIC 3177
  Complete submission text file 0001104659-20-065592.txt   113705
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filed by) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Subject) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-87472 | Film No.: 20907972
SIC: 2834 Pharmaceutical Preparations